1 min read
Add as a preferred source on GoogleModerna Shares Rise Just Over 14% to Set 52-Week High
The stock closed at $225 on Friday, Oct. 9, gaining $28 from the previous session as the mRNA medicine developer reached a new yearly peak.
Moderna shares rose just over 14% Friday, Oct. 9, closing at $225 and reaching a new 52-week high as the mRNA medicine developer posted a $28 gain from the previous session.
The move lifted Moderna’s stock from its prior close by roughly 14%, based on the dollar increase. The company develops messenger RNA medicines.
Enna Lee
ReporterEnna Lee reports on investing and digital-asset markets for TokenPost. Send corrections or tips to info@tokenpost.com.